Immune deposits in normal skin of patients with systemic lupus erythematosus: Relationship to the serum capacity to solubilize immune complexes

Abstract

Immunofluorescent deposits at the dermal-epidermal junction (DEJ) of the skin (lupus band test or LBT) were evaluated in 134 patients with various connective tissue diseases. LBT was found positive in 23 of 32 (71.8%) patients with systemic lupus erythematosus (SLE), in 3 of 53 (5.6%) patients with rheumatoid arthritis (RA), and in 1 of 5 cases of mixed connective tissue disease (MCTD). No deposits were found in patients with systemic sclerosis and with vasculitis. In patients with SLE a positive LBT showed a direct correlation with serum Clq binding activity (ClqBA) and with hypocomplementernia. The mean ClqBA was 13.49 ± 12.85 and 2.38 ± 2.27% in SLE patients with positive and negative band test, respectively ( P < 0.005). Likewise depressed mean serum levels of C3 and C4 were detected in patients with skin deposits ( P < 0.005). Sera from SLE patients showed an overall decreased capacity to solubilize preformed immune complexes when compared to normal sera. Furthermore 10 band-positive patients were less able to solubilize immune complexes than sera from LBT-negative lupus patients (45 ± 16 and 62 ± 11%, respectively; P < 0.01). Also the capacity to inhibit the precipitation of immune complexes was decreased in SLE patients with negative LBT ( P < 0.05). In conclusion our data suggest that in SLE patients a decreased complement-mediated solubilization of immune complexes is involved in the persistence of high levels of circulating immune aggregates and, considered its correlation with positive LBT, may be responsible for the deposits of immunoglobulins at the dermal-epidermal junction of the skin.